Pluri Inc. Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Aggregate Loss (Deprecated 2018-01-31)
Pluri Inc. (PLUR) reported Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Aggregate Loss (Deprecated 2018-01-31) of $36.00 thousand for the 9-month period ending 2014-03-31, per its 10-Q filed 2014-05-08.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses · last filed 2014-05-08
- Pluri Inc. available-for-sale securities, continuous unrealized loss position, less than 12 months, aggregate loss (deprecated 2018-01-31) for the quarter ending 2013-09-30 was $21.00K.
- Pluri Inc. available-for-sale securities, continuous unrealized loss position, less than 12 months, aggregate loss (deprecated 2018-01-31) for fiscal 2012 was -$224.00K.
| Period end | Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Aggregate Loss (Deprecated 2018-01-31) 3 month | Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Aggregate Loss (Deprecated 2018-01-31) 9 month | Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Aggregate Loss (Deprecated 2018-01-31) 12 month | Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Aggregate Loss (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|
| 2014-03-31 | $36.00K 10-Q · filed 2014-05-08 | |||
| 2013-09-30 | $21.00K 10-Q · filed 2013-11-05 | |||
| 2013-06-30 | $302.00K 10-Q · filed 2014-05-08 | -$302.00K 10-K · filed 2013-09-11 | ||
| 2012-06-30 | -$224.00K 10-K · filed 2013-09-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |